Trial Profile
Phase I study of irinotecan and cisplatin with concurrent thoracic radiotherapy in patients with limited-disease small cell lung cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Apr 2014
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Irinotecan (Primary)
- Indications Small cell lung cancer
- Focus Adverse reactions
- 23 Apr 2007 New trial record.